Table 1 Patient and tumor characteristics
Primary NSCLC N (%) | Lung Metastases N (%) | p-value | |
|---|---|---|---|
Number of Patients | 47 | 64 | |
Age (years) | < 0.001 | ||
Median | 74 | 65 | |
Range | (41 – 93) | (35 – 84) | |
Gender | 0.258 | ||
Male | 28 (60 %) | 31 (48 %) | |
Female | 19 (40 %) | 33 (52 %) | |
KPS (%) | 0.678 | ||
Median | 80 | 80 | |
Range | 60 – 100 | 60 – 100 | |
Prior Treatments | |||
None | 36 (77 %) | 17 (30 %) | |
Chemotherapy | 8 (17 %) | 39 (68 %) | |
Surgery | 3 (6 %) | 15 (26 %) | |
Immunotherapy | 0 (0 %) | 5 (9 %) | |
Radiofrequency Ablation | 0 (0 %) | 2 (4 %) | |
Other | 2 (4 %) | 3 (5 %) | |
Tumor Volume (cc) | 0.117 | ||
Median | 24.4 | 20.6 | |
Range | (2 – 280) | (0.3 – 147) | |
TNM status (n = 48) | |||
T1N0M0 | 27 (56 %) | ||
T2N0M0 | 21 (44 %) | ||
Tumor Histology (n = 48) | |||
Adenocarcinoma | 3 (6 %) | ||
Squamous Cell Carcinoma | 22 (46 %) | ||
NSCLC not specified | 23 (48 %) |